about
Role of mitochondria in nonalcoholic fatty liver diseaseReduced intestinal fat absorptive capacity but enhanced susceptibility to diet-induced fatty liver in mice heterozygous for ApoB38.9 truncationIn vivo MRS measurement of liver lipid levels in mice.Apolipoprotein B-containing lipoproteins in retinal aging and age-related macular degeneration.Nonsynonymous mutations within APOB in human familial hypobetalipoproteinemia: evidence for feedback inhibition of lipogenesis and postendoplasmic reticulum degradation of apolipoprotein BRecent progress in understanding protein and lipid factors affecting hepatic VLDL assembly and secretion.A genomewide search using an original pairwise sampling approach for large genealogies identifies a new locus for total and low-density lipoprotein cholesterol in two genetically differentiated isolates of Sardinia.Peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) stimulates VLDL assembly through activation of cell death-inducing DFFA-like effector B (CideB)Hepatocyte nuclear factor-4 alpha regulates liver triglyceride metabolism in part through secreted phospholipase A₂ GXIIB.Therapeutic RNA manipulation in liver disease.Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease.Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteins.Congenital diarrheal disorders: an updated diagnostic approach.Monogenic hypocholesterolaemic lipid disorders and apolipoprotein B metabolism.Thematic review series: patient-oriented research. What we have learned about VLDL and LDL metabolism from human kinetics studies.Mechanisms for cellular cholesterol transport: defects and human disease.Role of the gut in lipid homeostasisLipoprotein metabolism in nonalcoholic fatty liver diseasePathogenesis and Prevention of Hepatic Steatosis.Genetic variation and atherosclerosis.Assessing association between protein truncating variants and quantitative traitsLipoproteomics: using mass spectrometry-based proteomics to explore the assembly, structure, and function of lipoproteins.Development of Antisense Drugs for Dyslipidemia.A novel APOB mutation identified by exome sequencing cosegregates with steatosis, liver cancer, and hypocholesterolemia.Splicing therapeutics in SMN2 and APOB.Mea6 controls VLDL transport through the coordinated regulation of COPII assembly.Low LDL-C and high HDL-C levels are associated with elevated serum transaminases amongst adults in the United States: a cross-sectional study.Is the future of statins aligned with new novel lipid modulation therapies?Low-density lipoprotein cholesterol: how low can we go?Exon skipping of hepatic APOB pre-mRNA with splice-switching oligonucleotides reduces LDL cholesterol in vivo.The pathophysiology of intestinal lipoprotein production.Prospect and progress of gene therapy in treating atherosclerosis.Emerging Therapeutic Options for Lowering of Lipoprotein(a): Implications for Prevention of Cardiovascular Disease.Clinical Implications of Lipid Genetics for Cardiovascular Disease.Fatty liver in familial hypobetalipoproteinemia: roles of the APOB defects, intra-abdominal adipose tissue, and insulin sensitivity.Hepatic triglyceride contents are genetically determined in mice: results of a strain survey.New Sequencing technologies help revealing unexpected mutations in Autosomal Dominant Hypercholesterolemia.Clinical significance of APOB inactivation in hepatocellular carcinoma
P2860
Q27028142-8D6CFA5E-69B2-41D0-9E4D-FFBBB1E83EBAQ28508454-77E7C2EA-F930-409C-9524-B98382055BDFQ30924323-1EEE7435-9DA7-44BC-AF21-A52EC9340A32Q33634096-D796BBDB-72CF-4AA7-B519-B0293EB32774Q33673712-0AB35DCE-8802-4EB7-9D28-3EB42C39929AQ33863614-77E258C4-A5E3-45FC-8856-9756F2A1FA6CQ33910521-1609A1A3-A26A-46AA-8415-43FE4DF73EF4Q34074263-55092D45-2172-4C03-9903-56E1FB4CCB86Q34161197-276FA939-0450-4F73-A28A-589020BDE4ECQ34244756-0210292C-1B57-467E-A4B8-51AF848B0DF2Q34404491-190BB1F4-AC6B-4776-81C8-CF449F3D9C38Q35056603-94DA69EB-E8E3-40CD-AD14-38F6E0AFB9EAQ35933871-1AF42055-73C6-4C5F-A73F-AFA0AB9EB93BQ36359516-CDF156FD-2744-47A3-B61D-5E754D1D9828Q36487064-8C012A21-3782-4FE8-A665-976F6D853031Q36610465-93162506-0F7F-46D8-9937-5FE3CF10A519Q36660888-9B5A5C3A-A8C4-41D7-98A7-7B0A08E20CBFQ36682138-77694BB3-8FE1-457F-9557-EEED4DB75E60Q36812508-61F3D2AE-FBCD-441F-B4D2-C68AD17FC969Q37172163-0C0B15CC-81C8-4B78-B456-9DF971194E6DQ37182574-49263E83-E0A4-4ACC-968F-E3D2E1577E20Q37337498-56AC440A-944E-41C0-BDE6-B65DB84A2862Q37387192-E43150F1-FAE1-4989-8FCD-F2672CAB6FA3Q37408477-77EB9AFC-D4CA-4276-82D8-B2E394885BDDQ37426472-7B1CBA82-00DD-4C30-8AC4-F2E35DFA46F0Q37457316-1C32789D-DE41-4DE8-911F-C5248C31EF49Q37483995-29A2DC02-9C00-450D-9340-B72847ED32DBQ38073148-BA739B05-C989-4840-9F85-4AB8DB295817Q38100982-C607858E-0209-42D0-888C-B5FE6ACA6AB9Q38318522-10E205CC-C01B-4595-99D1-5DDA9B5E74D8Q38410893-83EF82DF-34DA-4C66-BA92-F7E2FBE86655Q38578275-AFA4A91A-BAC3-4726-A31D-9AF86612044BQ38985774-2BEF9A6A-BD9C-4581-B2CC-AC88767419AAQ42575072-BB0ADA78-18FC-48D1-895B-119BB303F97FQ44766939-8513B87A-AF52-4D84-835E-B7885899A3B1Q45182803-BAC34F2F-CC63-4B1D-BC89-2325C5D067C7Q48130479-B7699EE1-F304-4447-A88A-9C1FD212093FQ59131869-311FE8BD-1A56-4A94-A072-BF1C1B5586FE
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Familial hypobetalipoproteinemia: a review
@ast
Familial hypobetalipoproteinemia: a review
@en
Familial hypobetalipoproteinemia: a review
@nl
type
label
Familial hypobetalipoproteinemia: a review
@ast
Familial hypobetalipoproteinemia: a review
@en
Familial hypobetalipoproteinemia: a review
@nl
prefLabel
Familial hypobetalipoproteinemia: a review
@ast
Familial hypobetalipoproteinemia: a review
@en
Familial hypobetalipoproteinemia: a review
@nl
P2860
P3181
P1476
Familial hypobetalipoproteinemia: a review
@en
P2093
Gustav Schonfeld
P2860
P304
P3181
P356
10.1194/JLR.R300002-JLR200
P407
P577
2003-05-01T00:00:00Z